Inventor · disambiguated record
Stephen Monroe
Also filed as: MONROE STEPHEN H
7 granted patents·17 pending applications·280 citations·filing 1990–2013
89Inventor score
Top patents by PatentIndex Score
24 records- 0194US5800884AHigh gloss ultraviolet curable coating for porous substratesINT PAPER CO·Filed 1995·Granted Sep 1, 1998·78 cites·44 claims
- 0286US5492733AHigh gloss ultraviolet curable coatingINT PAPER CO·Filed 1993·Granted Feb 20, 1996·46 cites·24 claims
- 0374US2010196507A1Treatment of Wounds and Compositions EmployedGREYSTONE MEDICAL GROUP INC·Filed 2009·Application pending·0 cites
- 0473US5532298ADegradable agricultural matINT PAPER CO·Filed 1995·Granted Jul 2, 1996·32 cites·8 claims
- 0572US6171443B1Recyclable polymeric synthetic paper and method for its manufacturePOLYWEAVE INTERNATIONAL LLC·Filed 1995·Granted Jan 9, 2001·55 cites·18 claims
- 0669US2007298121A1Treatment of Wounds and Compositions EmployedMONROE STEPHEN H·Filed 2007·Application pending·0 cites
- 0766US5853541ADegradable cotton base cellulosic agricultural matINT PAPER CO·Filed 1996·Granted Dec 29, 1998·23 cites·13 claims
- 0866US2007190178A1Composition and method for the therapeutic modulation of matrix metalloproteinaseMONROE STEPHEN H·Filed 2007·Application pending·0 cites
- 0965US2007128296A1Reduction of reactive oxygen species in chronic wound managementGREYSTONE MEDICAL GROUP INC·Filed 2007·Application pending·0 cites
- 1064US5064692AMethod for producing paper products having increased gloss in which surface characteristics of a release film are imparted to coated substratesINT PAPER CO·Filed 1990·Granted Nov 12, 1991·24 cites·10 claims
- 1164US2006257501A1Composition and method for the therapeutic modulation of matrix metalloproteinaseMONROE STEPHEN H·Filed 2006·Application pending·0 cites
- 1260US2004170703A1Reduction of reactive oxygen species in chronic wound managementGREYSTONE MEDICAL GROUP INC·Filed 2003·Application pending·0 cites
- 1359US2004105897A1Composition and method for the therapeutic modulation of matrix metalloproteinaseGREYSTONE MEDICAL GROUP INC·Filed 2003·Application pending·0 cites
- 1458US2008220091A1Reduction of reactive oxygen species in chronic wound managementMONROE STEPHEN H·Filed 2008·Application pending·0 cites
- 1558US2007009611A1Treatment of wounds and compositions employedGREYSTONE MEDICAL GROUP INC·Filed 2006·Application pending·0 cites
- 1657US2010260863A1Composition of aqueous buffer solution for the treatment of cellular environment and ion channels and methods for using sameMONROE STEPHEN H·Filed 2008·Application pending·0 cites
- 1755US2005014838A1Method for treating vasculature degeneration and stimulating glucoseFiled 2004·Application pending·0 cites
- 1854US2006029682A1Treatment of wounds and compositions employedGREYSTONE MEDICAL GROUP INC·Filed 2005·Application pending·0 cites
- 1953US5616384ARecyclable polymeric label paperINT PAPER CO·Filed 1993·Granted Apr 1, 1997·22 cites·9 claims
- 2052US2005175715A1Cellular depolarization and regulation of matrix metalloproteinasesFiled 2004·Application pending·0 cites
- 2151US2003133991A1Treatment of wounds and compositions employedGREYSTONE MEDICAL GROUP INC·Filed 2002·Application pending·0 cites
- 2250US2004023937A1Anti-cancer formulationGREYSTONE MEDICAL GROUP INC·Filed 2003·Application pending·0 cites
- 2350US2014135284A1Composition of aqueous buffer solution for the treatment of cellular environment and ion channels and methods for using sameMONROE STEPHEN H·Filed 2013·Application pending·0 cites
- 2438US2011218618A1Self-Regenerating Drug-Delivering StentMONROE STEPHEN H·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →